<DOC>
	<DOCNO>NCT01953523</DOCNO>
	<brief_summary>To evaluate adverse effect may relate administration reception autologous adipose derive stromal vascular fraction ( SVF ) . Secondarily , study monitor result subjective objective finding applies non-blinded deployment autologous SVF various inflammatory and/or degenerative condition include select orthopedic , neurologic , urologic cardio-pulmonary condition . SVF deployment include intra-venous , intra-articular , soft tissue injection .</brief_summary>
	<brief_title>Safety Clinical Outcomes Study : SVF Deployment Orthopedic , Neurologic , Urologic , Cardio-pulmonary Conditions</brief_title>
	<detailed_description>SVF Stromal Vascular Fraction obtain lipoharvesting , procurement , lipo-transfer day operative procedure</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<criteria>Inclusion Criteria Patient must age 16 old Patient must degenerative disease inflammatory disease meet criteria treatment IRB include : Arthritis , Autoimmune disease , COPD , Cardiomyopathy , Peyronies Disease , Interstitial Cystitis , Erectile Dysfunction , Neurodegenerative disease Parkinsons , ALS , Neuropathy . Patient must healthy enough tolerate local anesthetic Patient must active cancer Patient must active infection</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>erectile dysfunction</keyword>
	<keyword>peyronies</keyword>
	<keyword>interstitial cystitis</keyword>
	<keyword>cardiomyopathy</keyword>
	<keyword>emphysema</keyword>
	<keyword>copd</keyword>
	<keyword>arthritis</keyword>
	<keyword>multiple sclerosis</keyword>
	<keyword>parkinson 's</keyword>
</DOC>